DarioHealth (NASDAQ: DRIO)
$1.15
(-5.0%)
-$0.06
Price as of April 18, 2024, 4:00 p.m. ET
DarioHealth Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
DarioHealth Company Info
DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.